Literature DB >> 508453

Haemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathy.

H Ikram, W Chan, S I Bennett, P J Bones.   

Abstract

Acebutolol ('Sectral'), a cardioselective beta-blocking drug, was administered intravenously in a dose of 25 mg to 10 patients with congestive cardiomyopathy. All of them were in a stable condition on antifailure regimens. The drug resulted in a statistically significant decline in left ventricular contractility as judged by peak left ventricular dP/dT and the contractility index. The mean aortic blood pressure also fell. There was a significant increase in end-diastolic and end-systolic left ventricular volumes. Mean values for heart rate, ejection fraction, left ventricular stroke work index, and cardiac output also fell, but the results were not statistically significant. Left ventricular distensibility as judged by the slope of the diastolic pressure-volume relation also improved significantly. A reduction in myocardial energy requirements, improved compliance, and lowering of arterial pressure would be haemodynamically advantageous. However, further cardiac dilatation and reduction contractility--the basic defects in congestive cardiomyopathy--could lead to further deterioration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508453      PMCID: PMC482153          DOI: 10.1136/hrt.42.3.311

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

Review 1.  The clinical pharmacology of beta-adrenoceptor-blocking drugs.

Authors:  M E Conolly; F Kersting; C T Dollery
Journal:  Prog Cardiovasc Dis       Date:  1976 Nov-Dec       Impact factor: 8.194

2.  MYOCARDIAL FUNCTION AND LEFT VENTRICULAR VOLUMES IN ACQUIRED VALVULAR INSUFFICIENCY.

Authors:  G A MILLER; J W KIRKLIN; H J SWAN
Journal:  Circulation       Date:  1965-03       Impact factor: 29.690

3.  DETERMINATION OF THE EXTERNAL WORK AND POWER OF THE LEFT VENTRICLE IN INTACT MAN.

Authors:  R E SNELL; P C LUCHSINGER
Journal:  Am Heart J       Date:  1965-04       Impact factor: 4.749

4.  Cardiac output and related measurements and pressure values in the right heart and associated vessels, together with an analysis of the hemo-dynamic response to the inhalation of high oxygen mixtures in healthy subjects.

Authors:  B G BARRATT-BOYES; E H WOOD
Journal:  J Lab Clin Med       Date:  1958-01

Review 5.  The cardiomyopathies.

Authors:  J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1972-06

6.  Left-ventricular endomyocardial biopsy.

Authors:  I A Brooksby; B S Jenkins; D J Coltart; M M Webb-Peploe; M J Davies
Journal:  Lancet       Date:  1974-11-23       Impact factor: 79.321

7.  Left ventricular stress and compliance in man. With special reference to normalized ventricular function curves.

Authors:  W H Gaasch; W E Battle; A A Oboler; J S Banas; H J Levine
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

8.  A method of left ventricular ejection fraction estimation from cineangiocardiograms employing a special-purpose calculator.

Authors:  P J Bones; H Ikram
Journal:  Cardiovasc Res       Date:  1977-09       Impact factor: 10.787

9.  Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).

Authors:  B S Lewis; A Bakst; A S Mitha; K Purdon; M S Gotsman
Journal:  Br Heart J       Date:  1973-07

Review 10.  Prospects and predictions for the cardiomyopathies.

Authors:  J F Goodwin
Journal:  Circulation       Date:  1974-08       Impact factor: 29.690

View more
  8 in total

Review 1.  Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies.

Authors:  F Waagstein
Journal:  Heart Vessels Suppl       Date:  1991

Review 2.  Beta receptor antagonists in the treatment of heart failure.

Authors:  H Persson; L Erhardt
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

3.  Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.

Authors:  N Galie; A Branzi; G Magnani; G Melandri; I Caldarera; C Rapezzi; C Grattoni; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

4.  Left Ventricular End-Systolic Volume Is a Reliable Predictor of New-Onset Heart Failure with Preserved Left Ventricular Ejection Fraction.

Authors:  Marina Kato; Shuichi Kitada; Yu Kawada; Kosuke Nakasuka; Shohei Kikuchi; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Cardiol Res Pract       Date:  2020-06-29       Impact factor: 1.866

Review 5.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.

Authors:  P DasGupta; A Lahiri
Journal:  Clin Investig       Date:  1992

Review 7.  Use of beta-adrenoceptor blockers in patients with congestive heart failure.

Authors:  V Panfilov; I Wahlqvist; G Olsson
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

Review 8.  Characterizing heart failure in the ventricular volume domain.

Authors:  Peter Lm Kerkhof
Journal:  Clin Med Insights Cardiol       Date:  2015-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.